A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis

Summary

The purpose of the study is to assess the efficacy of rozanolixizumab as measured by seizure freedom, change in cognitive function, use of rescue medication, onset of seizure freedom and to assess safety and tolerability.

Timeline

Start

2021-09-27

Primary completion

2024-03-08

Completion

2024-04-26

Outcome

Outcome not reported

Stopped: “The study stopped prematurely due to enrolment challenges, the termination was not linked to any safety issues.”

Drugs

Indications